Latest information on COVID-19

Cancer Clinical Trials

Stanford Cancer Institute offers leading edge research and compassionate care with over 250 actively recruiting clinical trials, investigating a broad spectrum of new diagnostic, prevention and treatment strategies.  

New Processes Due to COVID-19

We have implemented several positive measures to ensure our cancer clinical trial participants continue to receive their care safely during these difficult times. Our hope is that these new adaptations will continue to provide more equitable access to trials for all patients, including those in rural communities, the medically underserved, and communities of color, by reducing the burden of participation on our cancer patients.

  • Remote consenting of new and ongoing participants⁣
  • Offering virtual office visits, whenever possible⁣
  • Directly shipping orally administered study drugs to patients, whenever possible⁣

Get Alerts

Receive email alerts when trials open to patients.

General questions about our trials? Contact Us:

650-498-7061, ccto-office@stanford.edu

Note: This service only provides general information about how to find our trials. It does not provide doctor’s advice or a second opinion.



Discover Cancer Clinical Trials

Frequently Asked Questions

Our Stories